These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

134 related items for PubMed ID: 21491479

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Botulinum toxin type A for upper limb spasticity following stroke: an open-label study with individualised, flexible injection regimens.
    Slawek J, Bogucki A, Reclawowicz D.
    Neurol Sci; 2005 Apr; 26(1):32-9. PubMed ID: 15877185
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Botox produces functional weakness in non-injected muscles adjacent to the target muscle.
    Yaraskavitch M, Leonard T, Herzog W.
    J Biomech; 2008 Apr; 41(4):897-902. PubMed ID: 18184613
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. No change in calf muscle passive stiffness after botulinum toxin injection in children with cerebral palsy.
    Alhusaini AA, Crosbie J, Shepherd RB, Dean CM, Scheinberg A.
    Dev Med Child Neurol; 2011 Jun; 53(6):553-8. PubMed ID: 21574991
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Dramatic changes in muscle contractile and structural properties after 2 botulinum toxin injections.
    Minamoto VB, Suzuki KP, Bremner SN, Lieber RL, Ward SR.
    Muscle Nerve; 2015 Oct; 52(4):649-57. PubMed ID: 25598004
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. A randomised, double-blind, dose-ranging study to evaluate efficacy and safety of three doses of botulinum toxin type A (Botox) for the treatment of spastic foot.
    Mancini F, Sandrini G, Moglia A, Nappi G, Pacchetti C.
    Neurol Sci; 2005 Apr; 26(1):26-31. PubMed ID: 15877184
    [Abstract] [Full Text] [Related]

  • 17. Botulinum toxin has an increased effect when targeted toward the muscle's endplate zone: a high-density surface EMG guided study.
    Lapatki BG, van Dijk JP, van de Warrenburg BP, Zwarts MJ.
    Clin Neurophysiol; 2011 Aug; 122(8):1611-6. PubMed ID: 21195024
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Functional outcome of botulinum toxin injection of gastrocnemius and adductors in spastic hemiplegic cerebral palsied children.
    Ibrahim AI, Hawamdeh ZM, Al-Qudah AA.
    Eura Medicophys; 2007 Mar; 43(1):13-20. PubMed ID: 17021584
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.